Clinical Trial Update: A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer [Phase 1, Phase 2]

View source ↗

Summary

Trial NCT01522677 evaluating neoadjuvant photodynamic immunomodulation for colon cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Edward Nelson | Conditions: Colon Cancer | Phase 1, Phase 2 | Status: WITHDRAWN